This Article Full Text Full Text (PDF) All Versions of this Article: 41/2/207    most recent 01.HYP.0000044938.94050.E3v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Cui, J. S. Articles by Harrap, S. B. Search for Related Content PubMed PubMed Citation Articles by Cui, J. S. Articles by Harrap, S. B. Pubmed/NCBI databases Medline Plus Health Information Blood Pressure Medicines Related Collections Clinical genetics Cardiovascular Pharmacology Risk Factors Other hypertension Genomics Quantitative modeling Epidemiology Genetics of cardiovascular disease

(Hypertension. 2003;41:207.)
© 2003 American Heart Association, Inc.

Scientific Contributions

Antihypertensive Treatments Obscure Familial Contributions to Blood Pressure Variation

From the Centre for Genetic Epidemiology (J.S.C., J.L.H.) and the Department of Physiology (S.B.H.), The University of Melbourne, Parkville, Victoria, Australia.

Correspondence to Prof Stephen Harrap, Department of Physiology, The University of Melbourne, Parkville, Victoria 3010, Australia. E-mail s.harrap{at}unimelb.edu.au

The linkage and association between inherent blood pressure and underlying genotype is potentially confounded by antihypertensive treatment. We estimated blood pressure variance components (genetic, shared environmental, individual-specific) in 767 adult volunteer families by using a variety of approaches to adjusting blood pressure of the 244 subjects (8.2%) receiving antihypertensive medications. The additive genetic component of variance for systolic pressure was 73.9 mm Hg² (SE, 8.8) when measured pressures (adjusted for age by gender within each generation) were used but fell to 61.4 mm Hg² (SE, 8.0) when treated subjects were excluded. When the relevant 95th percentile values were substituted for treated systolic pressures, the additive genetic component was 81.9 mm Hg² (SE, 9.5), but individual adjustments in systolic pressure ranged from -53.5 mm Hg to +64.5 mm Hg (mean, +17.2 mm Hg). Instead, when 10 mm Hg was added to treated systolic pressure, the additive genetic component rose to 86.6 mm Hg² (SE, 10.1). Similar changes were seen in the shared environment component of variance for systolic pressure and for the combined genetic and shared environmental (ie, familial) components of diastolic pressure. There was little change in the individual-specific variance component across any of the methods. Therefore, treated subjects contribute important information to the familial components of blood pressure variance. This information is lost if treated subjects are excluded and obscured by treatment effects if unadjusted measured pressures are used. Adding back an appropriate increment of pressure restores familial components, more closely reflects the pretreatment values, and should increase the power of genomic linkage and linkage disequilibrium analyses.

Key Words: antihypertensive therapy • blood pressure • genetics • human • epidemiology

This article has been cited by other articles:

				L. Wang, F. Rao, K. Zhang, M. Mahata, J. L. Rodriguez-Flores, M. M. Fung, J. Waalen, M. G. Cockburn, B. A. Hamilton, S. K. Mahata, et al. Neuropeptide Y(1) Receptor NPY1R discovery of naturally occurring human genetic variants governing gene expression in cella as well as pleiotropic effects on autonomic activity and blood pressure in vivo. J. Am. Coll. Cardiol., September 1, 2009; 54(10): 944 - 954. [Abstract] [Full Text] [PDF]

				C. M.M. Licht, E. J.C. de Geus, A. Seldenrijk, H. P.J. van Hout, F. G. Zitman, R. van Dyck, and B. W.J.H. Penninx Depression Is Associated With Decreased Blood Pressure, but Antidepressant Use Increases the Risk for Hypertension Hypertension, April 1, 2009; 53(4): 631 - 638. [Abstract] [Full Text] [PDF]

				D. A. Blizard, A. Lionikas, D. J. Vandenbergh, T. Vasilopoulos, G. S. Gerhard, J. W. Griffith, L. C. Klein, J. T. Stout, H. A. Mack, J. M. Lakoski, et al. Blood pressure and heart rate QTL in mice of the B6/D2 lineage: sex differences and environmental influences Physiol Genomics, February 2, 2009; 36(3): 158 - 166. [Abstract] [Full Text] [PDF]

				C. Fava, M. Montagnana, P. Almgren, L. Rosberg, G. Lippi, B. Hedblad, G. Engstrom, G. Berglund, P. Minuz, and O. Melander The V433M Variant of the CYP4F2 Is Associated With Ischemic Stroke in Male Swedes Beyond Its Effect on Blood Pressure Hypertension, August 1, 2008; 52(2): 373 - 380. [Abstract] [Full Text] [PDF]

				I. Hajjar, D. T. Lackland, L. A. Cupples, and L. A. Lipsitz Association Between Concurrent and Remote Blood Pressure and Disability in Older Adults Hypertension, December 1, 2007; 50(6): 1026 - 1032. [Abstract] [Full Text] [PDF]

				C. J. Busst, K. J. Scurrah, J. A. Ellis, and S. B. Harrap Selective Genotyping Reveals Association Between the Epithelial Sodium Channel {gamma}-Subunit and Systolic Blood Pressure Hypertension, October 1, 2007; 50(4): 672 - 678. [Abstract] [Full Text] [PDF]

				E. Zintzaras, G. Kitsios, D. Kent, N. J. Camp, L. Atwood, P. N. Hopkins, and S. C. Hunt Genome-Wide Scans Meta-Analysis for Pulse Pressure Hypertension, September 1, 2007; 50(3): 557 - 564. [Abstract] [Full Text] [PDF]

				F. Rao, L. Zhang, J. Wessel, K. Zhang, G. Wen, B. P. Kennedy, B. K. Rana, M. Das, J. L. Rodriguez-Flores, D. W. Smith, et al. Tyrosine Hydroxylase, the Rate-Limiting Enzyme in Catecholamine Biosynthesis: Discovery of Common Human Genetic Variants Governing Transcription, Autonomic Activity, and Blood Pressure In Vivo Circulation, August 28, 2007; 116(9): 993 - 1006. [Abstract] [Full Text] [PDF]

				L. Dauchet, E. Kesse-Guyot, S. Czernichow, S. Bertrais, C. Estaquio, S. Peneau, A.-C. Vergnaud, S. Chat-Yung, K. Castetbon, V. Deschamps, et al. Dietary patterns and blood pressure change over 5-y follow-up in the SU.VI.MAX cohort Am. J. Clinical Nutrition, June 1, 2007; 85(6): 1650 - 1656. [Abstract] [Full Text] [PDF]

				J. M. Saavedra The Challenge of Genetic Studies in Hypertension Circ. Res., May 25, 2007; 100(10): 1389 - 1393. [Full Text] [PDF]

				F. Rao, G. Wen, J. R. Gayen, M. Das, S. M. Vaingankar, B. K. Rana, M. Mahata, B. P. Kennedy, R. M. Salem, M. Stridsberg, et al. Catecholamine Release-Inhibitory Peptide Catestatin (Chromogranin A352-372): Naturally Occurring Amino Acid Variant Gly364Ser Causes Profound Changes in Human Autonomic Activity and Alters Risk for Hypertension Circulation, May 1, 2007; 115(17): 2271 - 2281. [Abstract] [Full Text] [PDF]

				J.-J. Hottenga, J. B. Whitfield, D. Posthuma, G. Willemsen, E. J.C. de Geus, N. G. Martin, and D. I. Boomsma Genome-Wide Scan for Blood Pressure in Australian and Dutch Subjects Suggests Linkage at 5P, 14Q, and 17P Hypertension, April 1, 2007; 49(4): 832 - 838. [Abstract] [Full Text] [PDF]

				B. K. Rana, P. A. Insel, S. H. Payne, K. Abel, E. Beutler, M. G. Ziegler, N. J. Schork, and D. T. O'Connor Population-Based Sample Reveals Gene-Gender Interactions in Blood Pressure in White Americans Hypertension, January 1, 2007; 49(1): 96 - 106. [Abstract] [Full Text] [PDF]

				N. Iwai, K. Kajimoto, Y. Kokubo, and H. Tomoike Extensive Genetic Analysis of 10 Candidate Genes for Hypertension in Japanese Hypertension, November 1, 2006; 48(5): 901 - 907. [Abstract] [Full Text] [PDF]

				N. Franceschini, J. W. MacCluer, H. H.H. Goring, S. A. Cole, K. M. Rose, L. Almasy, V. Diego, S. Laston, E. T. Lee, B. V. Howard, et al. A Quantitative Trait Loci-Specific Gene-by-Sex Interaction on Systolic Blood Pressure Among American Indians: The Strong Heart Family Study Hypertension, August 1, 2006; 48(2): 266 - 270. [Abstract] [Full Text] [PDF]

				G. Bianchi Genetic variations of tubular sodium reabsorption leading to "primary" hypertension: from gene polymorphism to clinical symptoms Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2005; 289(6): R1536 - R1549. [Abstract] [Full Text] [PDF]

				P. R Burton, K. J Scurrah, M. D Tobin, and L. J Palmer Covariance components models for longitudinal family data Int. J. Epidemiol., October 1, 2005; 34(5): 1063 - 1077. [Abstract] [Full Text] [PDF]

				M. Bochud, P. Bovet, R. C. Elston, F. Paccaud, C. Falconnet, M. Maillard, C. Shamlaye, and M. Burnier High Heritability of Ambulatory Blood Pressure in Families of East African Descent Hypertension, March 1, 2005; 45(3): 445 - 450. [Abstract] [Full Text] [PDF]

				H. Ho, A. Pinto, S. D. Hall, D. A. Flockhart, L. Li, T. C. Skaar, P. Cadman, D. T. O'Connor, U. Wagner, N. S. Fineberg, et al. Association Between the CYP3A5 Genotype and Blood Pressure Hypertension, February 1, 2005; 45(2): 294 - 298. [Abstract] [Full Text] [PDF]

				N. Kupper, G. Willemsen, H. Riese, D. Posthuma, D. I. Boomsma, and E. J.C. de Geus Heritability of Daytime Ambulatory Blood Pressure in an Extended Twin Design Hypertension, January 1, 2005; 45(1): 80 - 85. [Abstract] [Full Text] [PDF]

				M. de Lange, T. D. Spector, and T. Andrew Genome-Wide Scan for Blood Pressure Suggests Linkage to Chromosome 11, and Replication of Loci on 16, 17, and 22 Hypertension, December 1, 2004; 44(6): 872 - 877. [Abstract] [Full Text] [PDF]

				S. B. Harrap, J. S. Cui, Z. Y. H. Wong, and J. L. Hopper Familial and Genomic Analyses of Postural Changes in Systolic and Diastolic Blood Pressure Hypertension, March 1, 2004; 43(3): 586 - 591. [Abstract] [Full Text] [PDF]

				N. J. Camp, P. N. Hopkins, S. J. Hasstedt, H. Coon, A. Malhotra, R. M. Cawthon, and S. C. Hunt Genome-Wide Multipoint Parametric Linkage Analysis of Pulse Pressure in Large, Extended Utah Pedigrees Hypertension, September 1, 2003; 42(3): 322 - 328. [Abstract] [Full Text] [PDF]